TITLE

New hope for functional dyspepsia?

AUTHOR(S)
Bytzer, Peter
PUB. DATE
June 2012
SOURCE
Gut;Jun2012, Vol. 61 Issue 6, p789
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article provides information related to functional dyspepsia (FD) in proximal gastrointestinal tract. It is mentioned that there are no known cause of FD and also mentions that epigastric pain is the common symptom of FD. It is also mentioned that empiric antisecretory therapy helps in the treatment of FD. It is suggested that additional clinical trial with acotiamide drug can help in understanding the pathogenesis of FD.
ACCESSION #
76111424

 

Related Articles

  • Fact or fiction? Defining dysbiosis. Jensen, Karen // Alive: Canada's Natural Health & Wellness Magazine;Mar2005, Issue 269, p44 

    Reports on the rise of gastrointestinal disorders which includes acute digestive conditions, indigestion, abdominal pain and bowel dysfunction in the U.S. Presentation of a questionnaire on the determination of underlying preconditions for dysbiosis; Description on the cause of dysbiosis;...

  • Indigestion. Jones, Francis Avery // Journal of the Royal Society of Medicine;Mar1983, Vol. 76 Issue 3, p175 

    The article provides information about the mechanisms and symptoms of indigestion. The author cites a study which makes a plea for more accurate definitions of indigestion and dyspepsia in medical writing. Symptoms of indigestion include re-tasting of food, water-brash, return of fluid into the...

  • STW 5, a Phytopharmacon for Patients With Functional Dyspepsia: Results of a Multicenter, Placebo-Controlled Double-Blind Study. von Arnim, Ulrike; Peitz, Ulrich; Vinson, Bettina; Gundermann, Karl-Josef; Malfertheiner, Peter // American Journal of Gastroenterology;Jun2007, Vol. 102 Issue 6, p1268 

    BACKGROUND: Functional dyspepsia (FD) constitutes a complex picture with a variety of epigastric symptoms. No standard therapy is currently available for FD. OBJECTIVE: This multicenter, placebo-controlled, double-blind study evaluated the efficacy and tolerability of the herbal drug STW 5,...

  • Mycophenolate mofetil/mycophenolate sodium.  // Reactions Weekly;10/24/2009, Issue 1275, p22 

    The article describes the case of twenty patients who developed upper gastrointestinal (GI) tract injury. Sixteen of the patient acquired the condition while undergoing treatment with mycophenolate mofetil, and the remaining four taking mycophenolate sodium. Symptoms patients experienced include...

  • Hangekobokuto (Banxia-houpo-tang), a Kampo Medicine that Treats Functional Dyspepsia. Oikawa, Tetsuro; Ito, Go; Hoshino, Takayuki; Koyama, Hidehiko; Hanawa, Toshihiko // Evidence-based Complementary & Alternative Medicine (eCAM);Sep2009, Vol. 6 Issue 3, p375 

    Although abdominal bloating is one of the most bothersome symptoms experienced by patients with functional dyspepsia (FD), therapeutic drugs to relieve abdominal bloating have not been established. We investigated the Kampo (Chinese herbal) medicine, Hangekobokuto (Banxiahoupo- tang, HKT) for...

  • Functional Dyspepsia: Motor Abnormalities, Sensory Dysfunction, and Therapeutic Options. Timmons, Suzanne; Liston, Richard; Moriarty, Kieran J. // American Journal of Gastroenterology;Apr2004, Vol. 99 Issue 4, p739 

    Functional dyspepsia is a common condition, but as yet, the underlying etiology is unclear. In this article, upper gastrointestinal motor and sensory physiology are reviewed and the current evidence for motor and/or sensory functional abnormalities causing dyspeptic symptoms is presented. The...

  • Benign Abdominal Pain.  // Clinical Pediatrics;Apr1974, Vol. 13 Issue 4, p382 

    The article focuses on a medical case of benign abdominal pain. A 17 year old Negro girl had abdominal pain, mainly periumbilical and in the right iliac fossa and associated with no other symptoms. Careful palpation showed tenderness at the McBurney's point, an oval tender mass in the right...

  • Implications of Melatonin Therapy in Irritable Bowel Syndrome: A Systematic Review. Mozaffari, Shilan; Rahimi, Roja; Abdollah, Mohammad // Current Pharmaceutical Design;11/28/2010, Vol. 16 Issue 33, p3646 

    No abstract available.

  • Efficacy of neodymium:YAG laser therapy for gastric antral vascular ectasia (GAVE) following hematopoietic cell transplant. Selinger, R. R. E.; McDonald, G. B.; Hockenbery, D. M.; Steinbach, G.; Kimmey, M. B. // Bone Marrow Transplantation;Jan2006, Vol. 37 Issue 2, p191 

    We determined the incidence of severe bleeding from gastric antral vascular ectasia (GAVE) after myeloablative hematopoietic cell transplant and the outcomes after treatment with endoscopic neodymium:YAG laser photocoagulation. From 1992 to 2005, the incidence of severe bleeding from GAVE was...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics